期刊文献+

75岁以上老年胃癌患者术前外周血中性粒细胞与淋巴细胞比值的临床意义 被引量:11

Prognostic value of preoperative neutrophil-to-lymphocyte ratio in the elderly patients over 75 years old with gastric cancer
原文传递
导出
摘要 目的探讨老年胃癌患者术前外周血中性粒细胞与淋巴细胞比值(NLR)的临床意义及NLR与患者预后的关系。方法回顾性分析2007年1月到2010年12月间在哈尔滨医科大学附属肿瘤医院胃肠外科行手术治疗的160例年龄≥75岁的胃癌患者临床资料。收集患者术前血常规中性粒细胞和淋巴细胞计数以计算NLR。通过受试者工作特征曲线确定NLR预测患者总体生存期的截点值,并根据该截点值将患者分为两组。比较两组患者临床病理特征;绘制Kaplan—Meier曲线进行生存分析,采用Cox回归模型进行多因素预后分析。结果NLR预测患者术后总生存期的截点值为1.83,其对应的敏感性和特异性分别为0.709和0.562。NLR〈1.83者为NLR-0组(54例),NLR≥1.83者为NLR-1组(106例)。NLR-1组与NLR-0组患者相比,肿瘤直径≥50mm[66.0%(70/106)比42.6%(23/54),P=0.004]、肿瘤侵出浆膜[75.5%(80/106)比57.4%(31/54),P=0.029]、淋巴结转移阳性[83.0%(88/106)比55.6%(30/54),P=0.001]和Ⅲ期患者[79.2%(84/106)比61.1%(33/54),P=0.013]所占比例明显增高。NLR-0组和NLR.1组中位生存时间分别为1209d和587d,差异有统计学意义(P=0.001)。多因素预后分析结果显示,NLR≥1.83(HR=1.800,95%口:1.039~3.116,P=0.036)、肿瘤侵出浆膜(HR=1.967,95%Ci1.082~3.573,P:0.026)及淋巴结转移(HR=5.263,95%CI:2.078~13.328,P=0.001)是影响老年胃癌患者生存期的独立危险因素。结论老年胃癌患者术前NLR升高提示患者病灶较大,肿瘤侵出浆膜及淋巴结转移的概率更高,临床分期更晚,预后较差。 Objective To investigate the clinical implication of preoperative neutrophil-to- lymphocyte ratio (NLR), and association of NLR with the prognosis of the elderly patients over 75 years old with primary gastric cancer. Methods Clinical data of 160 patients (≥75 years) with gastric cancer undergoing gastrectomy in Department of Gastrointestinal Surgery, the Tumour Hsopital of Harbin Medical University form January 2007 to December 2010 were retrospectively analyzed. Preoperative neutrophil and lymphocyte count was measured and NLR was calculated. The cut-off value of NLR to predict the survival was obtained from the receiver operating characteristic (ROC) curve. Patients were divided into two groups based on cut-off value. Clinicopathological features were compared between two groups using Chi-square test or Fisher exact test. Cox proportional hazard model was used to analyze risk factors associated with survival. Results The cut-off value of NLR was 1.83 with 0.709 of sensitivity and 0.562 of specificity. A total of 54 patients with NLR〈1.83 belonged to NLR-0 group, and 106 patients with NLR≥1.83 belonged to NLR-1 group. As compared to NLR-0 group, patients in NLR-1 group had significantly higher proportion in maximum tumor size≥50 mm [66.0%(70/106) vs. 42.6%(23/54), P= 0.004], serosal invasion [75.5%(80/106) vs. 57.4%(31/54), P= 0.029%, positive lymph node metastasis E83.0% (88/106) vs. 55.6%(30/54), P = 0.001] and TNM stage m [79.2%(84/106) vs. 61.1%(33/54), P= 0.013]. The median survival of NLR-0 and NLR-1 group was 1 209 days and 587 days respectively, with significant difference (P = 0.001). Multivariate analysis showed that NLR≥1.83 (HR = 0.530, 95% CI: 0.332 to 0.846, P= 0.008), serosal invasion (HR = 0.570, 95% CI: 0.332 to 0.979, P= 0.042), and lymph node metastasis(HR = 0.475, 95% CI: 0.462 to 1.685, P= 0.033) were independent risk factors of poor prognosis (all P 〈 0.05). Conclusion Preoperative higher NLR value in the elderly patients over 75 years old with primary gastric cancer indicates larger tumor size, severe serous invasion, more lymph node metastasis, later TNM staging, and poorer prognosis.
出处 《中华胃肠外科杂志》 CAS CSCD 北大核心 2016年第5期526-529,共4页 Chinese Journal of Gastrointestinal Surgery
关键词 胃肿瘤 老年人 中性粒细胞 淋巴细胞 预后 Stomach neoplasms Elderly Neutrophil Lymphocyte Prognosis
  • 相关文献

参考文献15

  • 1Fertay J, Soerjomataram I. cancer incidence and mortality wordwide: source, method, and major patterns in GLIBOCAN 2012[J]. Int J Cancer, 2015,136:E359-E386.
  • 2Grivennikov SI, Greten FR, Karin M. Immunity, inflammation,and cancer [J]. Cell, 2010, 140 (6) : 883-899. DOI : 10.1016/j. cell.2010.01.025.
  • 3Grivennikov SI, Karin M. Inflammation and oncogenesis: a vicious connection[J]. Curt Opin Genet Dev, 2010,20(1):65- 71. DOI : 10.1016/j.gde.2009.11.004.
  • 4Bhatti I, Peacock O, Lloyd G, et al. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio [ J ]. Am J Surg, 2010,200 ( 2 ) : 197 -203. DOI : 10.1016/j.amjsurg.2009.08.041.
  • 5Kim HS, Han KH, Chung HH, et al. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case- matched comparison [J]. Eur J Surg Oncol, 2010,36(7):691- 698. DOI : 10.1016/i.eiso.2010.05.004.
  • 6Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006[J]. CA Cancer J Clin, 2006,56(2):106-130.
  • 7陈凛,张勇,卫勃,赵向阳,李涛.2335例胃癌外科治疗的临床分析[J].中华胃肠外科杂志,2007,10(5):421-424. 被引量:33
  • 8陈惟,卢绮萍.白细胞介素6与消化道肿瘤关系的研究进展[J].中国普通外科杂志,2015,24(10):1457-1462. 被引量:7
  • 9Sun KY, Xu JB, Chen SL, et al. Novel immunological and nutritional-based prognostic index for gastric cancer[J]. World J Gastroenterol, 2015,21 (19) :5961-5971. DOI: 10.3748/wjg.v21. i19.5961.
  • 10Ishizuka M, Nagata H, Takagi K, et al. Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer [J]. Br J Cancer, 2013,109 (2) :401-407. DOI: 10.1038/ bjc.2013.350.

二级参考文献58

  • 1徐大志,詹友庆.胃癌切缘残留癌[J].国外医学(肿瘤学分册),2004,31(7):532-534. 被引量:3
  • 2詹友庆,李威,孙晓卫,陈映波,徐立,陈功,关远祥,李元方,徐大志,孙献甫,张华政,林振文.胃癌外科治疗的远期疗效研究[J].中华外科杂志,2005,43(17):1109-1113. 被引量:82
  • 3Allgayer H, Heiss MM, Schildberg FW, et al. Prognostic factors in gastric carcer. Br J Surg, 1997,84: 1651-1664.
  • 4Maehara Y, Kakeji Y, Koga T, et al. Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer. Surgery, 2002, 131(1s) :S85-91.
  • 5Liu KJ,Atten MJ,Donahue PE,et al. Extended lymphadenectomy for gastric cancer:results in a teaching hospital. Am J Surg, 2002,68 : 365-371.
  • 6Sun Z, Wang S, Zhao RC. The roles of mesenchymal stem cells in tumor inflammatory microenvironment[J]. J Hematol Oncol, 2014, 7:14. doi: 10.1186/1756-8722-7-14.
  • 7Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?[J]. Lancet, 2001, 357(9255):539-545.
  • 8Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials[J]. Int J Cancer, 2007, 121(11):2373-2380.
  • 9Kishimoto T. IL-6: from its discovery to clinical applications[J]. Int Immunol, 2010, 22(5):347-352.
  • 10Yu H, Pardoll D. Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3[J]. Nat Rev Cancer, 2009, 9(11):798-809.

共引文献38

同被引文献112

引证文献11

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部